Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2006 2
2007 2
2008 4
2009 4
2010 3
2011 2
2012 4
2013 4
2014 9
2015 10
2016 17
2017 11
2018 14
2019 20
2020 39
2021 63
2022 54
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro.
Pozzi V, Molinelli E, Campagna R, Serritelli EN, Cecati M, De Simoni E, Sartini D, Goteri G, Martin NI, van Haren MJ, Salvolini E, Simonetti O, Offidani A, Emanuelli M. Pozzi V, et al. Among authors: offidani a. Hum Cell. 2024 May;37(3):729-738. doi: 10.1007/s13577-024-01047-0. Epub 2024 Mar 19. Hum Cell. 2024. PMID: 38504052 Free PMC article.
Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Zouboulis CC, et al. Among authors: offidani a. Br J Dermatol. 2024 Mar 12:ljae098. doi: 10.1093/bjd/ljae098. Online ahead of print. Br J Dermatol. 2024. PMID: 38470171
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).
Orsini D, Malagoli P, Balato A, Bianchi L, Brianti P, Buononato D, Burlando M, Caldarola G, Campanati A, Campione E, Carrera CG, Carugno A, Cusano F, Dapavo P, Dattola A, De Simone C, Dini V, Esposito M, Fargnoli MC, Gaiani FM, Gargiulo L, Gisondi P, Giunta A, Ibba L, Lasagni C, Loconsole F, Maione V, Mortato E, Marzano AV, Maurelli M, Megna M, Mercuri SR, Narcisi A, Offidani A, Paolino G, Parodi A, Pellacani G, Potestio L, Quaglino P, Richetta AG, Romano F, Sena P, Venturini M, Assorgi C, Costanzo A. Orsini D, et al. Among authors: offidani a. Dermatol Pract Concept. 2024 Apr 1. doi: 10.5826/dpc.1402a52. Online ahead of print. Dermatol Pract Concept. 2024. PMID: 38416060 Free article.
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).
Gargiulo L, Narcisi A, Ibba L, Balato A, Bianchi L, Brianti P, Buononato D, Burlando M, Caldarola G, Campanati A, Campione E, Carrera CG, Carugno A, Cristaudo A, Cusano F, Dapavo P, Dattola A, De Simone C, Gaiani FM, Gisondi P, Giunta A, Loconsole F, Maione V, Mortato E, Marzano AV, Maurelli M, Megna M, Mercuri SR, Offidani A, Orsini D, Parodi A, Pellacani G, Potestio L, Quaglino P, Richetta AG, Romano F, Sena P, Venturini M, Malagoli P, Costanzo A. Gargiulo L, et al. Among authors: offidani a. Front Med (Lausanne). 2023 Aug 8;10:1243843. doi: 10.3389/fmed.2023.1243843. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614958 Free PMC article.
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review.
Rizzetto G, De Simoni E, Molinelli E, Offidani A, Simonetti O. Rizzetto G, et al. Among authors: offidani a. Int J Mol Sci. 2023 Aug 3;24(15):12383. doi: 10.3390/ijms241512383. Int J Mol Sci. 2023. PMID: 37569757 Free PMC article. Review.
250 results